Google News – Pharmaceuticals External News
Life Sciences & Pharma Articles
Google News – Biopharma External News
Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. - New Castle News
Google News – Pharmaceuticals External News
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know - Yahoo Finance
Google News – Pharmaceuticals External News
Are Pharmaceutical Stocks Ready to Take Off? Here's What I See - Kiplinger
Google News – Oncology External News
Medicus Pharma Prioritises CD228V Oncology Programme in Development Strategy - Yahoo Finance
Google News – Pharmaceuticals External News
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome - The Manila Times
Google News – FDA (biotech/pharma) External News
Project Optimus explained: what the FDA expects on oncology dosing - The Pharma Letter
Google News – Pharmaceuticals External News
NRx Pharmaceuticals to Participate in Upcoming Investor Conferences - Investing News Network
Google News – Pharmaceuticals External News
Barclays Upgrades Hikma Pharmaceuticals to Equalweight, Boosts PT - marketscreener.com
Google News – Pharmaceuticals External News
Chief medical shake-up at Mirum Pharmaceuticals (NASDAQ: MIRM) includes new leader and exit deal - Stock Titan
Google News – Clinical Trials External News
Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo - ACCESS Newswire
Google News – Biopharma External News
Can-Fite BioPharma Reports H1 2026 Clinical Progress and Financial Results, Including Promising Survival Data in Pancreatic and Liver Cancer Studies - Quiver Quantitative
Google News – Pharmaceuticals External News
Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer - Yahoo Finance
Google News – Biopharma External News
Vor Biopharma (VOR) Completes Enrollment in Phase 3 Trial as Market Eyes Growth Potential - GuruFocus
Google News – Pharmaceuticals External News

